Cargando…

Health risks associated with the pharmaceuticals in wastewater

The overwhelming population growth in recent decades and water crisis along with limited and uneven geographical distribution of fresh water resources is a growing challenge for the economic and human development. Wastewater reclamation and use could be an alternative for intact water sources and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassiri Koopaei, Nasser, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389172/
https://www.ncbi.nlm.nih.gov/pubmed/28403898
http://dx.doi.org/10.1186/s40199-017-0176-y
_version_ 1782521243513126912
author Nassiri Koopaei, Nasser
Abdollahi, Mohammad
author_facet Nassiri Koopaei, Nasser
Abdollahi, Mohammad
author_sort Nassiri Koopaei, Nasser
collection PubMed
description The overwhelming population growth in recent decades and water crisis along with limited and uneven geographical distribution of fresh water resources is a growing challenge for the economic and human development. Wastewater reclamation and use could be an alternative for intact water sources and a promising solution to water scarcity and unequal distribution. However, wastewater is a double-edged resource both as an accessible water source for food production and human usage and concurrently may carry uncharacterized content with unknown toxicological profile causing acute or long-term health risks. Pharmaceuticals, cosmeceuticals, nanomaterials and their chemical decomposition derivatives found in wastewater are not well known in many cases. Their unknown toxicity, teratogenicity and carcinogenicity profile associated with lack of monitoring and control measures impose a significant hazard risk on the public health. This paper reviews the evidence on the health risks associated with the wastewater use for irrigated food production and the imposed risk on the end consumers mainly from pharmaceutical industry and related research facilities. Then, we suggest an applied framework for planning and policy-making to mitigate the health risks and optimally employ reclaimed wastewater for human purposes.
format Online
Article
Text
id pubmed-5389172
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53891722017-04-14 Health risks associated with the pharmaceuticals in wastewater Nassiri Koopaei, Nasser Abdollahi, Mohammad Daru Editorial The overwhelming population growth in recent decades and water crisis along with limited and uneven geographical distribution of fresh water resources is a growing challenge for the economic and human development. Wastewater reclamation and use could be an alternative for intact water sources and a promising solution to water scarcity and unequal distribution. However, wastewater is a double-edged resource both as an accessible water source for food production and human usage and concurrently may carry uncharacterized content with unknown toxicological profile causing acute or long-term health risks. Pharmaceuticals, cosmeceuticals, nanomaterials and their chemical decomposition derivatives found in wastewater are not well known in many cases. Their unknown toxicity, teratogenicity and carcinogenicity profile associated with lack of monitoring and control measures impose a significant hazard risk on the public health. This paper reviews the evidence on the health risks associated with the wastewater use for irrigated food production and the imposed risk on the end consumers mainly from pharmaceutical industry and related research facilities. Then, we suggest an applied framework for planning and policy-making to mitigate the health risks and optimally employ reclaimed wastewater for human purposes. BioMed Central 2017-04-12 /pmc/articles/PMC5389172/ /pubmed/28403898 http://dx.doi.org/10.1186/s40199-017-0176-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Editorial
Nassiri Koopaei, Nasser
Abdollahi, Mohammad
Health risks associated with the pharmaceuticals in wastewater
title Health risks associated with the pharmaceuticals in wastewater
title_full Health risks associated with the pharmaceuticals in wastewater
title_fullStr Health risks associated with the pharmaceuticals in wastewater
title_full_unstemmed Health risks associated with the pharmaceuticals in wastewater
title_short Health risks associated with the pharmaceuticals in wastewater
title_sort health risks associated with the pharmaceuticals in wastewater
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389172/
https://www.ncbi.nlm.nih.gov/pubmed/28403898
http://dx.doi.org/10.1186/s40199-017-0176-y
work_keys_str_mv AT nassirikoopaeinasser healthrisksassociatedwiththepharmaceuticalsinwastewater
AT abdollahimohammad healthrisksassociatedwiththepharmaceuticalsinwastewater